Drug's Long-Term kidney impact under watch in japan
NCT ID NCT06527846
Summary
This study is monitoring the long-term safety and effectiveness of Jardiance tablets in over 1,000 real-world patients with chronic kidney disease in Japan. It aims to see how well the drug works and what side effects occur when used daily over a long period. The study is not testing a new treatment but observing patients already prescribed this medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY DISEASE, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nippon Boehringer Ingelheim Co., Ltd.
Tokyo, 1416017, Japan
Conditions
Explore the condition pages connected to this study.